Skip to content
Tenderpoints
Tenderpoints™Hub
Cellular Energy & Genetics

Medical Biochemistry & Metabolism

Complete rate-limiting enzyme catalogs, inborn errors of metabolism decoder (GSDs, LSDs, amino acid defects), electron transport chain inhibitors, and clinical vitamin matrices.

7 Master Pathway Diagrams
16 Storage GSD & LSD Diseases
13 Vitamins Master Matrix
14 Visual Clinical Slides
Board Mastery Core Central Dogma • PDH • Sugar Shunts

Genetic Code Characteristics, PDH Cofactors & Galactosemia

The Genetic Code
  • • Unambiguous: Each codon specifies only ONE amino acid.
  • • Degenerate / Redundant: Most amino acids are coded by multiple codons (wobble hypothesis at 3rd base position; exceptions: Methionine AUG, Tryptophan UGG).
  • • Nonoverlapping & Commaless: Read continuously from fixed start codon AUG in triplets without punctuation.
  • • Universal: Conserved across all species (slight exception in mitochondrial DNA).
Pyruvate Dehydrogenase Cofactors

The 5 cofactors of the Pyruvate Dehydrogenase (PDH) and α-Ketoglutarate Dehydrogenase complexes:

"Tender Loving Care For Nancy"
• T: Thiamine pyrophosphate (TPP, Vitamin B1)
• L: Lipoic acid (inhibited by arsenic poisoning)
• C: Coenzyme A (CoA, from Pantothenic acid / Vitamin B5)
• F: FAD (from Riboflavin / Vitamin B2)
• N: NAD+ (from Niacin / Vitamin B3)
Galactokinase vs Classic Galactosemia
Galactokinase Deficiency:

Mild, benign condition. Galactitol accumulates in lens → infantile cataracts (failure to track objects/social smile), galactose in urine. No hepatic or renal dysfunction.

Classic Galactosemia (GALT Defect):

Severe autosomal recessive deficiency of Galactose-1-Phosphate Uridyltransferase → toxic accumulation of Galactose-1-phosphate → cataracts, vomiting, jaundice, hepatomegaly, failure to thrive, intellectual disability, and life-threatening Escherichia coli sepsis in neonates.

Vitamin B5 & Refeeding Syndrome
• Pantothenic Acid (Vitamin B5): Essential component of Coenzyme A (acyl transfer) and fatty acid synthase. Deficiency causes paresthesias and burning feet sensation ("burning feet syndrome"), dermatitis, and enteritis.
Refeeding Syndrome:

In chronically starved patients (anorexia nervosa, severe alcoholism), carbohydrate refeeding triggers massive insulin surge → drives rapid cellular uptake of phosphate, potassium, and magnesium → profound hypophosphatemia → depleted ATP → arrhythmias, respiratory muscle failure, rhabdomyolysis, seizures, and death.

Interactive Metabolic Pathway Systems

Vector diagrams illustrating rate-limiting enzymes, allosteric control, electron flow, and clinical poison sites.

Catabolism vs. Anabolism Cytosol / ER Bypass

Glycolysis vs. Gluconeogenesis Switchpoints

Master control points at PFK-1 / FBPase-1 and Pyruvate Kinase / PEPCK with reciprocal allosteric regulation by Fructose-2,6-bisphosphate.

Board Pearl: PFK-1 is activated by AMP and Fructose-2,6-bisphosphate (produced by PFK-2). Glucagon phosphorylates PFK-2/FBPase-2 → activates FBPase-2 → gluconeogenesis turns ON.
Mitochondrial Matrix 10 ATP / Acetyl-CoA

Tricarboxylic Acid (Krebs) Cycle & Anaplerosis

The 8-step hub generating 3 NADH, 1 FADH2, and 1 GTP per turn, with TLCFN cofactor requirements for PDH and α-KGDH complexes.

Board Pearl: Isocitrate Dehydrogenase is the rate-limiting enzyme (inhibited by ATP and NADH; activated by ADP). Succinate DH doubles as Complex II of the ETC.
Oxidative Phosphorylation Inner Mitochondrial Membrane

Electron Transport Chain Complexes & Inhibitors

Chemiosmotic proton pumping across Complexes I–IV driving ATP synthesis at Complex V, with exact binding sites of pharmacologic toxins and uncouplers.

Board Pearl: Direct inhibitors (Rotenone, Antimycin, Cyanide, CO, Oligomycin) decrease O2 consumption. Uncoupling agents (DNP, Aspirin, Thermogenin) increase O2 consumption and dissipate heat.
Antioxidant Defense & Nucleotides Cytosol (NADPH)

Pentose Phosphate Pathway (HMP Shunt) & G6PD

Oxidative irreversible branch generating NADPH for glutathione reduction and fatty acid synthesis; non-oxidative branch synthesizing Ribose-5-P via Transketolase.

Board Pearl: G6PD deficiency is X-linked recessive; oxidative stress (fava beans, sulfa, infections) causes Heinz body formation and splenic "bite cells" (degmacytes).
Organ Energetics Timeline Fed • Fasting • Starvation

Fuel Homeostasis: Fed, Fasting & Starvation Switchboard

Chronological organ adaptation across postprandial (0-4h), fasting (4-24h), early starvation (1-3d), and prolonged starvation states, with hepatic ketogenesis regulation.

Board Pearl: The liver synthesizes ALL circulating ketone bodies for peripheral tissues, BUT the liver CANNOT utilize ketones because it lacks Thiophorase (Succinyl-CoA:3-ketoacid CoA transferase)!

Master Rate-Limiting Enzymes & Allosteric Regulators

The exact biochemical switchpoints targeted on COMLEX Level 1 and USMLE Step 1.

Pathway Rate-Limiting Enzyme Allosteric Activators (+) Allosteric Inhibitors (-) Cellular Compartment & Notes
Glycolysis Phosphofructokinase-1 (PFK-1) AMP, Fructose-2,6-bisphosphate (F-2,6-BP) ATP, Citrate Cytosol. Insulin activates PFK-2 → ↑F-2,6-BP → stimulates glycolysis. Glucagon stimulates FBPase-2.
Gluconeogenesis Fructose-1,6-bisphosphatase-1 Citrate, ATP AMP, F-2,6-BP Cytosol (Liver/Kidney). 4 unique bypass enzymes: Pyruvate carboxylase (biotin), PEP carboxykinase, F-1,6-BPase, Glucose-6-phosphatase.
TCA (Krebs) Cycle Isocitrate Dehydrogenase ADP, NAD+ ATP, NADH Mitochondrial matrix. Produces 3 NADH, 1 FADH2, 1 GTP per acetyl-CoA (10 ATP total per acetyl-CoA).
Glycogenesis Glycogen Synthase Glucose-6-phosphate, Insulin, Cortisol Epinephrine, Glucagon (via PKA phosphorylation) Cytosol. Forms α-1,4 bonds. Branching enzyme forms α-1,6 linkages.
Glycogenolysis Glycogen Phosphorylase Epinephrine, Glucagon, AMP, Ca2+ (calmodulin in muscle) Glucose-6-phosphate, ATP, Insulin Cytosol. Cleaves α-1,4 bonds yielding glucose-1-phosphate. Deficient in McArdle (muscle) and Hers (liver).
HMP Shunt (Pentose Phosphate) Glucose-6-Phosphate Dehydrogenase (G6PD) NADP+ NADPH Cytosol. Yields NADPH (for glutathione reduction, fatty acid/sterol synthesis) & Ribose-5-P (for nucleotides). G6PD deficiency → Heinz bodies & bite cells under oxidative stress.
Fatty Acid Synthesis Acetyl-CoA Carboxylase (ACC) Insulin, Citrate Glucagon, Palmitoyl-CoA Cytosol. Requires biotin (B7), ATP, and CO2. Product malonyl-CoA inhibits carnitine palmitoyltransferase-1 (CPT-1) to halt beta-oxidation.
Fatty Acid Beta-Oxidation Carnitine Acyltransferase I (CPT-1) Glucagon, low malonyl-CoA Malonyl-CoA (synthesis intermediate) Mitochondrial outer membrane → matrix. Carnitine shuttle transports long-chain fatty acids into matrix. Systemic carnitine deficiency → hypoketotic hypoglycemia.
Ketogenesis HMG-CoA Synthase Fasting, low oxaloacetate, high acetyl-CoA Insulin Liver mitochondria only (RBCs cannot use ketones, lack mitochondria; liver cannot use ketones, lacks thiophorase/SCOT).
Cholesterol Synthesis HMG-CoA Reductase Insulin, Thyroxine Statins (competitive), Glucagon, Cholesterol Smooth ER. Converts HMG-CoA to mevalonate. Statins competitively inhibit; side effects = myopathy & hepatotoxicity.
Urea Cycle Carbamoyl Phosphate Synthetase I (CPS I) N-acetylglutamate (NAG) Low arginine Mitochondria (CPS I & OTC); Cytosol (Argininosuccinate synthetase/lyase, Arginase). NAG is an obligate allosteric activator.

Electron Transport Chain Complexes & Classic Poisons

High-yield mechanism correlations tested on toxicological and cellular respiration questions.

Complex I Inhibitors Rotenone • Metformin

Directly halts electron transfer from NADH to CoQ (Ubiquinone), eliminating the proton gradient from Complex I.

Complex III Inhibitors Antimycin A

Blocks electron transfer from Cytochrome b to Cytochrome c1, freezing upstream cytochromes in reduced state.

Complex IV Inhibitors Cyanide • Carbon Monoxide • Azide

Inhibits Cytochrome c oxidase (Fe3+ in Cyanide, Fe2+ in CO). Halts cellular aerobic respiration; severe lactic acidosis with high venous oxygen saturation in cyanide.

ATP Synthase & Uncouplers Oligomycin vs 2,4-DNP / Aspirin

Oligomycin directly blocks F0 proton pore (halts ATP & electron flow). 2,4-DNP & Aspirin dissipate proton gradient as heat → hyperthermia, tachypnea, ↑O2 consumption.

Electron Transport Chain & Oxidative Phosphorylation

Mitochondrial proton electrochemical gradient, Complexes I–V, specific chemical inhibitors, and fatal uncoupling agents.

Mitochondrial Inner Membrane

Complexes & Electron Shuttles

  • Complex I (NADH Dehydrogenase): Transfers electrons from NADH to Coenzyme Q (Ubiquinone). Pumps 4 H+ into intermembrane space.
  • Complex II (Succinate Dehydrogenase): Only enzyme shared by TCA cycle and ETC! Transfers electrons from FADH2 to Coenzyme Q. Pumps NO protons.
  • Complex III (Cytochrome bc1): Transfers electrons from Coenzyme Q to Cytochrome c. Pumps 4 H+.
  • Complex IV (Cytochrome c Oxidase): Contains copper (Cu) and heme irons (a/a3). Transfers electrons to molecular O2 to form H2O. Pumps 2 H+.
  • Complex V (ATP Synthase / F0F1): Uses proton-motive force to spin F1 subunit and synthesize ATP from ADP + Pi.
Board Favorite Distinction

ETC Inhibitors vs. Uncoupling Agents

Direct ETC Inhibitors (Blocks Electron Flow)

Halts electron flow → proton gradient collapses → ↓ O2 consumption, ↓ ATP synthesis, lactic acidosis.

Complex I: Rotenone, Amytal, Metformin • Complex III: Antimycin A • Complex IV: Cyanide, CO, Sodium Azide, H2S • Complex V: Oligomycin

Uncoupling Agents (Increases Membrane Permeability)

Increases inner membrane H+ permeability → dissipates proton gradient without passing through ATP synthase → ↑ O2 consumption, ↓ ATP synthesis, energy released as massive heat.

Agents: 2,4-Dinitrophenol (DNP - illegal fat burner), High-dose Aspirin (hyperthermia, tachypnea), Thermogenin (UCP-1 in brown fat of newborns).

Specialized Hexoses

Fructose, Galactose & The Sorbitol Osmotic Pathway

Comparative enzyme deficiencies, cellular trapping mechanics, and polyol diabetic microvascular complications.

High-Yield Board Traps
F

Fructose Disorders

Fructokinase (Benign) vs. Aldolase B (Fatal Phosphate Trapping)
Essential Fructosuria Fructokinase Defect

Autosomal recessive, completely benign & asymptomatic. Fructose cannot be phosphorylated to F-1-P; it simply accumulates in the blood and is excreted freely in urine.

Board Trap: Reducing sugar in urine (positive copper reduction / Clinitest) BUT urine glucose dipstick is negative (glucose oxidase specific).
Hereditary Fructose Intolerance (HFI) Aldolase B Defect

Autosomal recessive, life-threatening. Fructose-1-Phosphate accumulates → traps intracellular inorganic phosphate (Pi) → severe ATP depletion → inhibits glycogenolysis and gluconeogenesis.

Classic Vignette: Healthy infant recently introduced to fruit, fruit juices, honey, or table sugar (weaning). Presents with profound fasting hypoglycemia, vomiting, jaundice, hepatomegaly, cirrhosis, and renal Fanconi dysfunction.

Critical Rx: Strictly eliminate all dietary Fructose, Sucrose (glucose + fructose), and Sorbitol.
G

Galactose Disorders

Galactokinase (GALK) vs. Classic Galactosemia (GALT)
Galactokinase (GALK) Deficiency Milder / Cataracts Only

Autosomal recessive. Galactose accumulates and is shunted into Galactitol via Aldose Reductase. Galactitol exerts osmotic pressure in the ocular lens.

Key Presentation: Infantile cataracts, failure to track moving objects or lack of social smile. Absence of hepatic or renal damage.
Classic Galactosemia (GALT Defect) Severe / Multi-Organ Failure

Autosomal recessive. Deficiency of Galactose-1-Phosphate Uridyltransferase → toxic accumulation of Galactose-1-P and Galactitol across the lens, liver, and brain.

Classic Vignette: Develops within days of initiating breast milk or cow-milk formula: failure to thrive, jaundice, hepatosplenomegaly, bilateral oil-droplet cataracts, intellectual disability, and life-threatening Escherichia coli neonatal sepsis.

Critical Rx: Immediate exclusion of galactose and lactose from diet (switch to soy formula). High risk of fatal E. coli sepsis!
S

The Sorbitol Polyol Pathway & Diabetic Complications

Aldose Reductase vs. Sorbitol Dehydrogenase tissue disparity in chronic hyperglycemia
Osmotic Cellular Lysis
Two-Step Enzymatic Cascade:
Step 1: Glucose + NADPH → Sorbitol + NADP+ (Aldose Reductase)
Step 2: Sorbitol + NAD+ → Fructose + NADH (Sorbitol Dehydrogenase)

Tissues equipped with both enzymes (Liver, Ovaries, Seminal vesicles) readily metabolize sorbitol to fructose without damage. In semen, fructose provides essential motility fuel for spermatozoa.

Pathophysiology of Diabetic Complications:

In uncontrolled diabetes mellitus, chronic hyperglycemia saturates Hexokinase/Glucokinase. Excess intracellular glucose floods Aldose Reductase, generating massive quantities of intracellular Sorbitol. Because target tissues lack or have negligible Sorbitol Dehydrogenase, polar sorbitol cannot cross membranes and is trapped, pulling in water osmotically and causing cell edema, oxidative stress (via NADPH depletion), and cellular lysis.

High-Yield Target Organs: The "LuRKS" Rule (Low/No Sorbitol Dehydrogenase)
L
Lens Osmotic Fiber Rupture
Ocular

Intracellular sorbitol accumulation pulls water osmotically into the lens matrix → hydropic fiber degeneration and opacity formation → classic diabetic cataracts (snowflake cataracts).

Pearl: High aldose reductase activity + zero sorbitol dehydrogenase = acute osmotic vulnerability.
R
Retina (Pericytes) Microvascular Weakening
Retinopathy

Selective osmotic loss of retinal pericytes → capillary wall outpouching → microaneurysms, dot-and-blot hemorrhages, and cotton-wool spots → diabetic retinopathy.

Pearl: Pericyte drop-out is the cardinal early histological finding in diabetic microangiopathy.
K
Kidneys (Mesangium & Podocytes) Glomerular Sclerosis
Nephropathy

Sorbitol hyperosmolarity combined with advanced glycation end-products (AGEs) → mesangial expansion, GBM thickening → Kimmelstiel-Wilson nodular glomerulosclerosis.

Pearl: Causes hyperfiltration followed by progressive microalbuminuria and end-stage renal disease.
S
Schwann Cells Segmental Demyelination
Neuropathy

Osmotic swelling damages Schwann cell architecture → segmental demyelination and axonal degeneration → symmetric distal stocking-glove polyneuropathy and autonomic dysfunction.

Pearl: Loss of vibratory sense (large fiber) followed by thermal/pain insensitivity and foot ulcers.
Fuel Homeostasis

Fed vs. Fasting States: 4-Phase Metabolic Timeline

Organ fuel priorities, hormone-driven enzyme switches, and protein-sparing adaptation in extended starvation.

Master Metabolic Pivot
Metabolic Phase Timeframe Endocrine Profile Primary Blood Glucose Source Peripheral Tissue Fuel Brain Fuel
1. Absorptive (Well-Fed) 0 – 4 hours post-meal High Insulin / Low Glucagon Exogenous dietary carbohydrates Glucose (GLUT-4 in muscle & adipose); liver stores glycogen & synthesizes TAGs 100% Glucose
2. Postabsorptive (Early Fast) 4 – 18 hours Falling Insulin / Rising Glucagon & Epinephrine Hepatic Glycogenolysis (primary); early onset of gluconeogenesis Adipose lipolysis via HSL releases FFAs; muscle switches to Free Fatty Acids (FFAs) 100% Glucose
3. Early Starvation 18 hours – 3 days Very Low Insulin / High Glucagon, Cortisol, Epinephrine Hepatic Gluconeogenesis (glycogen stores fully exhausted by ~24h). Substrates: muscle amino acids (alanine), lactate, and adipose glycerol. Free Fatty Acids (FFAs) & early Ketone Bodies. Liver floods with FFAs → excess Acetyl-CoA → Ketogenesis begins. Glucose (primary) + emerging Ketone Bodies
4. Extended Starvation > 3 days – weeks Basal Insulin / Sustained Glucagon & Epinephrine Renal & Hepatic Gluconeogenesis (minimal glucose required, protein-sparing state) Adipose FFAs; vital muscle protein degradation is dramatically suppressed to maintain diaphragm and myocardium β-Hydroxybutyrate & Acetoacetate (~70% of total energy); ~30% Glucose
Erythrocyte (RBC) Fuel Rule: Red blood cells completely lack mitochondria. Therefore, RBCs can never utilize fatty acids or ketone bodies; they rely 100% on anaerobic glycolysis to lactate in all metabolic states!
100% Board Testable
Toxicology & Metabolism

Ethanol Metabolism & The High NADH/NAD+ Ratio Cascade

Zero-order kinetics, targeted pharmacology, and the four fatal metabolic shifts of alcoholic hypoglycemia and ketoacidosis.

Classic Vignette Scenario
1

Cytosolic Step: Alcohol Dehydrogenase (ADH)

Zero-Order Elimination Kinetics • High-Yield Antidote Target
Enzymatic Reaction:
Ethanol + NAD+ → Acetaldehyde + NADH + H+

Operates by zero-order elimination kinetics at clinical alcohol levels because ADH is saturated at very low ethanol concentrations (~10 mg/dL). A constant amount (~7–10 g/hour or ~1 drink/hour) is cleared regardless of serum level.

Pharmacology: Fomepizole Competitive ADH Inhibitor

First-line antidote for Methanol (windshield wiper fluid → optic neuritis/blindness via formic acid) and Ethylene Glycol (automotive antifreeze → acute tubular necrosis / calcium oxalate monohydrate envelope crystals via glycolic/oxalic acid). Fomepizole blocks ADH, halting the production of toxic organic acids.

2

Mitochondrial Step: Acetaldehyde Dehydrogenase (ALDH)

Aversive Reaction Mechanics • Disulfiram-Like Medications
Enzymatic Reaction:
Acetaldehyde + NAD+ → Acetate + NADH + H+

Acetaldehyde is toxic and vasoreactive. Its accumulation causes facial flushing, nausea, throbbing headache, diaphoresis, and reflex tachycardia. Polymorphic inactive ALDH2 (*2 allele) is highly prevalent in East Asian populations.

Pharmacology: Disulfiram (Antabuse) Irreversible ALDH Inhibitor

Prescribed for alcohol abstinence by inducing violent physical aversion upon alcohol ingestion. High-Yield Board Rule: Medications triggering disulfiram-like reactions with alcohol include Metronidazole, Cefoperazone / Cefotetan, Griseofulvin, and 1st-generation sulfonylureas.

The 4 Classic Derangements of Elevated NADH/NAD+ Ratio

Both ADH and ALDH generate NADH, depleting cellular NAD+ and violently reversing dehydrogenase equilibria
Zero-Order Poisoning
1
Severe Fasting Hypoglycemia Gluconeogenesis Arrest (OAA Depletion)
Life-Threatening
Oxaloacetate + NADH + H+ → Malate + NAD+

Massive cytosolic NADH drives the malate dehydrogenase equilibrium strongly toward malate, effectively depleting intracellular oxaloacetate (OAA). Because OAA is the obligate substrate for PEPCK, hepatic gluconeogenesis is completely paralyzed.

Classic Board Vignette:

Chronic malnourished alcoholic found unresponsive on Sunday morning with blood glucose 24 mg/dL. Hepatic glycogen stores were depleted from malnutrition, and gluconeogenesis was shut down by alcohol metabolism.

2
Lactic Acidosis High Anion Gap Metabolic Acidosis
Acid-Base
Pyruvate + NADH + H+ → Lactate + NAD+

Surplus NADH forces lactate dehydrogenase (LDH) to convert pyruvate into lactate. This not only strips the cell of pyruvate (compounding gluconeogenesis failure) but causes severe systemic lactic acidosis with elevated anion gap.

Classic Lab Profile:

ABG demonstrates pH 7.20, HCO3 11 mEq/L, and anion gap of 24 with serum lactate 7.2 mmol/L in the absence of sepsis, shock, or tissue hypoperfusion.

3
Hepatic Steatosis (Fatty Liver) Triglyceride Esterification Surge
Hepatology
DHAP + NADH + H+ → Glycerol-3-Phosphate + NAD+

Elevated NADH shifts dihydroxyacetone phosphate (DHAP) toward glycerol-3-phosphate. Glycerol-3-P acts as the carbon backbone for esterifying circulating fatty acids into triglycerides, creating rapid macrovesicular steatosis.

Clinical Correlate:

Painless hepatomegaly with hyperechoic liver on ultrasound, AST:ALT ratio > 2:1 (mitochondrial AST leakage), and elevated serum triglycerides. Reversible with alcohol cessation.

4
Alcoholic Ketoacidosis (AKA) Surplus Ketogenesis & False (-) Dipstick
Endocrine / Tox
Acetoacetate + NADH + H+ → β-Hydroxybutyrate + NAD+

High NADH inhibits isocitrate DH and α-KGDH, stalling the TCA cycle. Surplus acetyl-CoA is shunted into ketogenesis. High NADH shifts acetoacetate almost entirely into β-hydroxybutyrate.

Major Board Trap:

Standard urine dipstick (nitroprusside) is falsely negative or only trace positive because nitroprusside reacts ONLY with acetoacetate, NOT β-hydroxybutyrate!

5th Board Pearl — Acute Gout Attack After Binge: Lactic acid competes with uric acid for organic acid transporters (URAT1/OAT) in the renal proximal tubules → reduced uric acid clearance → sudden hyperuricemic spike precipitating acute gouty arthritis in the 1st MTP joint (podagra).
High Yield COMLEX
12

Master Fed vs. Fasting Hormonal Signal & Enzyme Phosphorylation Matrix

The definitive board rule: Insulin promotes DEPHOSPHORYLATION; Glucagon & Epinephrine promote PHOSPHORYLATION.

Universal Board High Yield
Fed State: High Insulin / Glucagon Ratio
Storage Mode

Signaling Pathway: Insulin binds Receptor Tyrosine Kinase (RTK) → autophosphorylation → IRS-1/2 recruitment → PI3K/Akt pathway activation → stimulates Protein Phosphatase 1 (PP1).

Enzyme Effect: PP1 strips phosphate groups off key enzymes → Enzymes become DEPHOSPHORYLATED.

Net Metabolic Flux: Glycogen synthesis ON, Glycolysis ON, Fatty acid synthesis ON, Protein translation ON. Breakdown pathways shut OFF.

Fasting & Stress: High Glucagon & Epinephrine
Mobilization Mode

Signaling Pathway: Glucagon (liver) & Epinephrine (β receptors) bind Gs GPCR → stimulates Adenylyl Cyclase → ↑ cAMP → activates Protein Kinase A (PKA).

Enzyme Effect: PKA transfers ATP phosphates onto serine/threonine residues → Enzymes become PHOSPHORYLATED.

Net Metabolic Flux: Glycogenolysis ON, Gluconeogenesis ON, Lipolysis (adipose) ON, Ketogenesis (liver) ON. Storage pathways shut OFF.

Key Metabolic Pacemaker Pathway Dephosphorylated (Insulin / PP1) Phosphorylated (Glucagon / PKA) Crucial Board Takeaway & Allosteric Modulators
Glycogen Synthase Glycogenesis ACTIVE (Stores glycogen) INACTIVE Allosterically activated by Glucose-6-Phosphate in liver & muscle.
Glycogen Phosphorylase Glycogenolysis INACTIVE (Phosphorylase b) ACTIVE (Phosphorylase a) Activated by Phosphorylase Kinase (activated by PKA and Ca2+-calmodulin during muscle contraction). Allosteric activator in muscle: AMP. Inhibitors: ATP, G6P.
Bifunctional Enzyme:
PFK-2 / FBPase-2
Glycolytic Switch PFK-2 is ACTIVE
↑ Fructose-2,6-bisphosphate
→ Powerful allosteric activation of PFK-1 (Glycolysis ON)
FBPase-2 is ACTIVE
↓ Fructose-2,6-bisphosphate
→ Relieves inhibition of FBPase-1 (Gluconeogenesis ON)
High-Yield Mnemonic: "fabulous Fed Peasants" (Fed = PFK-2 active). In fasting, PKA phosphorylates both domains → inactivates kinase, activates phosphatase.
Pyruvate Dehydrogenase (PDH) Pyruvate → Acetyl-CoA ACTIVE (PDH Phosphatase stimulated by Ca2+, Mg2+, insulin) INACTIVE (PDH Kinase stimulated by ATP, NADH, Acetyl-CoA) High mitochondrial energy charge (ATP, NADH, Acetyl-CoA) shuts off PDH via kinase activation → shunts pyruvate to oxaloacetate via Pyruvate Carboxylase (gluconeogenesis).
Acetyl-CoA Carboxylase (ACC) Fatty Acid Synthesis ACTIVE (Polymerized form; produces Malonyl-CoA) INACTIVE (Phosphorylated by AMPK and PKA) Rate-limiting enzyme of lipogenesis. Requires Biotin (B7). Its product, Malonyl-CoA, allosterically inhibits Carnitine Palmitoyltransferase-I (CPT-I), preventing simultaneous β-oxidation!
Hormone-Sensitive Lipase (HSL) Adipocyte Lipolysis INACTIVE (Lipolysis halted) ACTIVE (Hydrolyzes stored triacylglycerols → FFAs + glycerol) Insulin strongly suppresses HSL via PP1, preventing ketoacidosis. In untreated Type 1 DM (zero insulin), uninhibited HSL floods liver with free fatty acids → massive ketogenesis and DKA.